Publications

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model.

Authors: T-SZ Fang, Y Sun, AC Pearce, S Eleuteri, M Kemp, CA Luckhurst, R Williams, ...

Research group: Jackson Group

E-pub date: 13 Nov 2023

Journal name: Nature Communications

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

Authors: FAM Saner, K Takahashi, T Budden, A Pandey, D Ariyaratne, TA Zwimpfer, NS M...

Research group: Brenton Group

E-pub date: 10 Nov 2023

Journal name:

The in vitro dynamics of pseudo-vascular network formation

Authors: M-E Oraiopoulou, D-L Couturier, EV Bunce, I Cannell, M Golinska, G Hannon, ...

Research group: Hannon Group, Bohndiek Group

E-pub date: 7 Nov 2023

Journal name:

Proteomic profiling of centrosomes across multiple mammalian cell and tissue types by an affinity capture method.

Authors: S Carden, E Vitiello, I Rosa E Silva, J Holder, V Quarantotti, K Kishore, V...

Research group: Proteomics

E-pub date: 6 Nov 2023

Journal name: Dev Cell

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Authors: JT Baeten, ICC Chan, L Moukarzel, AC Carter, M Patel, KH Stopsack, P Pharoa...

Research group: Brenton Group

E-pub date: 2 Nov 2023

Journal name: Blood

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Authors: SR Corcoran, J Choi, RE Fenner, X Yu, S Scheich, T Hsiao, G Schevchenko, VM...

Research group: Proteomics

E-pub date: 2 Nov 2023

Journal name: Blood

ZAP-70 Integrates Tonic B Cell Receptor and Chemokine Signaling in IGHV unmutated Chronic Lymphocytic Leukemia

Authors: C Jingyu, V Sathiaseelan, C Chilamakuri, C Jakwerth, CS D'Santos, I Ringsha...

Research group: Proteomics

E-pub date: 2 Nov 2023

Journal name: Blood

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach

Authors: M Reinius, A Crombé, T Bradley, R Barker-Clarke, M Crispin-Ortuzar, JD Bre...

Research group: Brenton Group

E-pub date: 1 Nov 2023

Journal name: Annals of Oncology

Filters

Research Groups

Core Facilities

Start date

End date

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model.

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

The in vitro dynamics of pseudo-vascular network formation

Proteomic profiling of centrosomes across multiple mammalian cell and tissue types by an affinity capture method.

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

ZAP-70 Integrates Tonic B Cell Receptor and Chemokine Signaling in IGHV unmutated Chronic Lymphocytic Leukemia

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model.

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

The in vitro dynamics of pseudo-vascular network formation

Proteomic profiling of centrosomes across multiple mammalian cell and tissue types by an affinity capture method.

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

ZAP-70 Integrates Tonic B Cell Receptor and Chemokine Signaling in IGHV unmutated Chronic Lymphocytic Leukemia

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach